Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gribben

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Clinical Advances in Hematology & Oncology : H&O|December 20, 2021
Umbralisib and ublituximab: an upcoming regimen for chronic lymphocytic leukemiaJohn Gribben
Expert Review of Hematology|April 4, 2013
Bendamustine for non-Hodgkin lymphoma. Interview by Louise RishtonJohn Gribben
Clinical Advances in Hematology & Oncology : H&O|October 10, 2015
New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspectiveFabienne McClanahan, John Gribben
Hematology/Oncology Clinics of North America|December 3, 2014
Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?Fabienne McClanahan, John Gribben
Seminars in Oncology|April 18, 2006
Vaccine- and immune-based therapy in chronic lymphocytic leukemiaRifca Le Dieu, John Gribben
Journal of HIV Therapy|January 3, 2006
CD40 activation: lessons for HIV immunotherapy from malignancies?Rifca Le Dieu, John Gribben
Hemasphere|June 7, 2021
The EHA2021 Annual Congress Award Winners: Celebrating Excellence in HematologyJohn Gribben, Elizabeth Macintyre, Pieter Sonneveld
Hemasphere|July 11, 2020
EU-Wide Access to High-quality, Affordable Precision Diagnostics: An EHA Position PaperElizabeth Macintyre, John Gribben, Konstanze Döhner
Case Reports in Hematology|July 17, 2024
Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated RiskThomas Erblich, Charlotte Manisty, John Gribben
Hemasphere|January 25, 2020
Here to Stay: Biosimilars in HematologyJohn Gribben, Giampaolo Merlini, Anton Hagenbeek
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Clinical Advances in Hematology & Oncology : H&O|December 20, 2021
Umbralisib and ublituximab: an upcoming regimen for chronic lymphocytic leukemiaJohn Gribben
Expert Review of Hematology|April 4, 2013
Bendamustine for non-Hodgkin lymphoma. Interview by Louise RishtonJohn Gribben
Clinical Advances in Hematology & Oncology : H&O|October 10, 2015
New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspectiveFabienne McClanahan, John Gribben
Hematology/Oncology Clinics of North America|December 3, 2014
Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?Fabienne McClanahan, John Gribben
Seminars in Oncology|April 18, 2006
Vaccine- and immune-based therapy in chronic lymphocytic leukemiaRifca Le Dieu, John Gribben
Journal of HIV Therapy|January 3, 2006
CD40 activation: lessons for HIV immunotherapy from malignancies?Rifca Le Dieu, John Gribben
Hemasphere|June 7, 2021
The EHA2021 Annual Congress Award Winners: Celebrating Excellence in HematologyJohn Gribben, Elizabeth Macintyre, Pieter Sonneveld
Hemasphere|July 11, 2020
EU-Wide Access to High-quality, Affordable Precision Diagnostics: An EHA Position PaperElizabeth Macintyre, John Gribben, Konstanze Döhner
Case Reports in Hematology|July 17, 2024
Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated RiskThomas Erblich, Charlotte Manisty, John Gribben
Hemasphere|January 25, 2020
Here to Stay: Biosimilars in HematologyJohn Gribben, Giampaolo Merlini, Anton Hagenbeek
Pageof 11